Your browser is no longer supported. Please, upgrade your browser.
Settings
AKRX Akorn, Inc. daily Stock Chart
AKRX [NASD]
Akorn, Inc.
Index- P/E- EPS (ttm)-3.23 Insider Own1.50% Shs Outstand120.54M Perf Week3.55%
Market Cap421.89M Forward P/E16.13 EPS next Y0.22 Insider Trans1.24% Shs Float92.64M Perf Month-14.22%
Income-404.90M PEG- EPS next Q-0.07 Inst Own76.90% Short Float9.23% Perf Quarter-7.16%
Sales694.00M P/S0.61 EPS this Y-683.30% Inst Trans4.85% Short Ratio3.20 Perf Half Y-73.84%
Book/sh3.54 P/B0.99 EPS next Y2200.00% ROA-23.40% Target Price6.75 Perf Year-81.18%
Cash/sh- P/C- EPS next 5Y15.00% ROE-61.20% 52W Range3.14 - 19.81 Perf YTD3.24%
Dividend- P/FCF- EPS past 5Y-55.30% ROI-28.10% 52W High-82.33% Beta2.76
Dividend %- Quick Ratio2.40 Sales past 5Y16.90% Gross Margin35.40% 52W Low11.46% ATR0.25
Employees2191 Current Ratio3.40 Sales Q/Q-17.60% Oper. Margin-56.00% RSI (14)43.95 Volatility4.87% 7.68%
OptionableYes Debt/Eq1.85 EPS Q/Q-136.00% Profit Margin-57.90% Rel Volume0.89 Prev Close3.36
ShortableYes LT Debt/Eq1.85 EarningsFeb 28 BMO Payout- Avg Volume2.67M Price3.50
Recom2.70 SMA20-7.14% SMA50-10.24% SMA200-63.45% Volume2,376,489 Change4.17%
Mar-20-19Initiated SunTrust Hold
Oct-17-18Upgrade Piper Jaffray Neutral → Overweight
Jul-25-18Reiterated RBC Capital Mkts Sector Perform $25 → $27
Apr-25-17Downgrade Piper Jaffray Overweight → Neutral
Apr-25-17Downgrade Jefferies Buy → Hold
Apr-25-17Downgrade Gabelli & Co Buy → Hold
Mar-10-17Reiterated WallachBeth Hold $22 → $25
Dec-01-16Initiated Goldman Sell
Nov-07-16Downgrade WallachBeth Buy → Hold $40 → $22
Nov-07-16Downgrade BofA/Merrill Buy → Underperform
Nov-04-16Downgrade RBC Capital Mkts Outperform → Sector Perform $37 → $24
Sep-15-16Upgrade Piper Jaffray Neutral → Overweight
Aug-05-16Reiterated WallachBeth Buy $39 → $40
Aug-05-16Downgrade Deutsche Bank Buy → Hold $33 → $33
Aug-02-16Downgrade Raymond James Outperform → Mkt Perform
Mar-18-16Reiterated Deutsche Bank Buy $40 → $33
Feb-12-16Reiterated RBC Capital Mkts Outperform $52 → $37
Dec-02-15Upgrade Nomura Neutral → Buy
Sep-29-15Initiated Nomura Neutral
Sep-09-15Initiated JMP Securities Mkt Perform
Mar-22-19 09:18PM  FINAL DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
05:10PM  AKRX INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Akorn, Inc. Investors Business Wire
Mar-21-19 06:29PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline AKRX GlobeNewswire
08:14AM  Block & Leviton LLP Reminds Shareholders of Important Deadlines: MU, AKRX, SYNH, CTL GlobeNewswire
07:00AM  Akorn Names Erislandy (Dandy) Dorado-Boladeres as Executive Vice President of Global Quality GlobeNewswire
Mar-20-19 09:09PM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Akorn, Inc. AKRX GlobeNewswire
04:00PM  Class Action AKRX, AMRN & CAG Bronstein, Gewirtz & Grossman, LLC Update GlobeNewswire
02:50PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akorn, Inc. To Contact The Firm Business Wire
09:48AM  Bronstein, Gewirtz & Grossman, LLC Class Action Update AKRX, AMRN & CAG ACCESSWIRE
Mar-19-19 08:30PM  LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akorn, Inc. To Contact The Firm PR Newswire
06:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline AKRX ACCESSWIRE
10:00AM  Class Action Update AKRX, AMRN & CAG Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
Mar-18-19 10:38AM  Block & Leviton LLP Reminds Shareholders of Important Deadlines: MU, AKRX, SYNH, CTL GlobeNewswire
Mar-17-19 08:45AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline AKRX ACCESSWIRE
Mar-15-19 02:00PM  Akorn, Inc. (AKRX) Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against and Lead Deadline: April 22, 2019 GlobeNewswire -7.90%
09:10AM  Akorn, Inc. (AKRX) Bronstein, Gewirtz & Grossman, LLC Reminds Stockholders of Class Action Against and Lead Plaintiff Deadline: April 22, 2019 ACCESSWIRE
Mar-14-19 09:18PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline  AKRX GlobeNewswire
10:51AM  Block & Leviton LLP Reminds Shareholders of Important Deadlines: MU, AKRX, SYNH, CTL GlobeNewswire
10:10AM  Akorn, Inc. (AKRX) Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against and Lead Plaintiff Deadline: April 22, 2019 ACCESSWIRE
Mar-13-19 08:50AM  Options Traders Expect Huge Moves in Akorn (AKRX) Stock Zacks -6.15%
Mar-12-19 08:25PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akorn, Inc. of Class Action Lawsuit and Upcoming Deadline AKRX ACCESSWIRE
03:33PM  AKRX DEADLINE ALERT: Zhang Investor Law Reminds of April 22 Deadline in Securities Class Action Lawsuit Against Akorn, Inc. AKRX GlobeNewswire
Mar-11-19 06:53PM  AKRX INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Akorn, Inc. Investors GlobeNewswire
10:09AM  Akorn, Inc. (AKRX) Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action Against and Lead Deadline: April 22, 2019 ACCESSWIRE
Mar-08-19 04:17PM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Akorn, Inc. Investors GlobeNewswire
11:50AM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Akorn, Inc. - AKRX ACCESSWIRE
10:13AM  Edited Transcript of AKRX earnings conference call or presentation 28-Feb-19 3:00pm GMT Thomson Reuters StreetEvents
Mar-07-19 06:59PM  Pomerantz Law Firm Announces the Filing of a Class Action against Akorn, Inc. and Certain Officers  AKRX GlobeNewswire
04:10PM  AKORN, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Akorn, Inc. GlobeNewswire
12:28PM  INVESTOR ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Akorn, Inc. - AKRX PR Newswire
Mar-05-19 10:30PM  Pomerantz Law Firm Announces the Filing of a Class Action against Akorn, Inc. and Certain Officers AKRX ACCESSWIRE
10:31AM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
10:16AM  TAP, AKRX & HIIQ Class Action - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
Mar-04-19 12:02PM  Akorn, Inc. (AKRX) Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against and Lead Plaintiff Deadline: April 22, 2019 ACCESSWIRE -7.23%
10:53AM  IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
10:16AM  TAP, AKRX & HIIQ Class Action Reminder Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
Mar-03-19 09:02PM  Akorn, Inc. (AKRX) Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against and Lead Plaintiff Deadline: April 22, 2019 ACCESSWIRE
05:10PM  TAP, AKRX & HIIQ Class Action Update Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
Mar-01-19 06:02PM  IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire +5.93%
05:17PM  Akorn Comments on Favorable Court Order GlobeNewswire
03:42PM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Akorn, Inc. AKRX GlobeNewswire
11:29AM  Pomerantz Law Firm Announces the Filing of a Class Action against Akorn, Inc. and Certain Officers  AKRX GlobeNewswire
Feb-28-19 09:14PM  Akorn (AKRX) Q4 2018 Earnings Conference Call Transcript Motley Fool +6.30%
03:43PM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Akorn, Inc. (AKRX) and Lead Deadline: April 22, 2019 ACCESSWIRE
01:09PM  Akorn, Inc. Investigated by Block & Leviton LLP For Violations of Federal Securities Laws GlobeNewswire
12:42PM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Akorn, Inc. (AKRX) and Deadline: April 22, 2019 ACCESSWIRE
11:56AM  FDA flags concerns at Akorn's Amityville plant, shares slip Reuters
10:04AM  AKRX, AMRN & CAG Bronstein, Gewirtz & Grossman, LLC Class Action Reminder ACCESSWIRE
07:33AM  FDA flags sanitation concerns at Akorn's Amityville plant Reuters
07:00AM  Akorn Provides Fourth Quarter and Full Year 2018 Results GlobeNewswire
Feb-27-19 04:05PM  AKORN, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois against Akorn, Inc. GlobeNewswire -7.52%
03:41PM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Akorn, Inc. (AKRX) and Lead Plaintiff Deadline: April 22, 2019 ACCESSWIRE
12:40PM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Stockholders of Class Action Against Akorn, Inc. (AKRX) and Lead Plaintiff Deadline: April 22, 2019 ACCESSWIRE
Feb-26-19 04:19PM  AKRX ALERT: Zhang Investor Law Announces the Filing of a Securities Class Action Lawsuit Against Akorn, Inc. AKRX GlobeNewswire
10:03AM  AKRX, AMRN & CAG Class Action Reminder Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
Feb-25-19 05:42PM  INVESTOR ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Akorn, Inc. AKRX GlobeNewswire
04:07PM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Akorn, Inc. (AKRX) Lead Plaintiff Deadline: April 22, 2019 ACCESSWIRE
12:06PM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Akorn, Inc. (AKRX) and Lead Plaintiff Deadline: April 22, 2019 ACCESSWIRE
Feb-24-19 04:20PM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akorn, Inc. (AKRX) and Lead Plaintiff Deadline: April 22, 2019 ACCESSWIRE
03:45PM  Class Action Update AKRX, AMRN & CAG Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
Feb-22-19 02:53PM  INVESTOR ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akorn, Inc. (AKRX) and Lead Plaintiff Deadline: April 22, 2019 ACCESSWIRE
01:03PM  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Akorn, Inc. Business Wire
11:52AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akorn, Inc. (AKRX) and Lead Plaintiff Deadline: April 22, 2019 ACCESSWIRE
09:51AM  STOCKHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akorn, Inc. (AKRX) and Lead Plaintiff Deadline: April 22, 2019 ACCESSWIRE
Feb-21-19 03:41PM  EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Akorn, Inc. AKRX Business Wire
03:10PM  Akorn, Inc. (AKRX) Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation ACCESSWIRE
Feb-20-19 05:25PM  Akorn Comments on Fresenius Proposed Amended Claims GlobeNewswire -9.21%
09:38AM  AKRX INVESTOR LOSSES ALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Akorn, Inc.; Akorn Investors are Encouraged to Contact the Firm AKRX GlobeNewswire
Feb-15-19 04:12PM  Akorn, Inc. -- Moody's announces completion of a periodic review of ratings of Akorn, Inc. Moody's
10:09AM  EQUITY ALERT: Rosen Law Firm Continues to Investigate Securities Claims Against Akorn, Inc. AKRX GlobeNewswire
Feb-11-19 04:38PM  Akorn to Report Fourth Quarter and Full Year 2018 Results GlobeNewswire
Feb-01-19 01:02PM  ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Jan-31-19 02:16PM  INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire -7.62%
12:27PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akorn, Inc. (AKRX) GlobeNewswire
Jan-30-19 02:43PM  INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akorn, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
11:19AM  EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Akorn, Inc. AKRX Business Wire
10:12AM  Akorn, Inc. Investigated by Block & Leviton LLP For Violations of Federal Securities Laws GlobeNewswire
Jan-28-19 04:30PM  Akorn Announces New Executive and Board Appointments GlobeNewswire -5.49%
Jan-10-19 02:54PM  Akorn (AKRX) Gets FDA Warning Letter for Illinois Facility Zacks
Jan-09-19 07:07PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akorn, Inc. - AKRX PR Newswire -11.68%
06:40PM  Akorn, Inc. -- Moody's says receipt of FDA Warning Letter on Akorn's Decatur facility is credit negative Moody's
12:46PM  Akorn gets FDA warning letter for Illinois plant, shares drop Reuters
12:09PM  Akorn Slides After Reporting FDA Warning Letter On Illinois Facility Benzinga
08:04AM  Akorn gets warning letter from the FDA Reuters
08:01AM  Akorn receives 'warning letter' from FDA related to a manufacturing facility MarketWatch
07:55AM  Akorn Receives FDA Warning Letter GlobeNewswire
Jan-08-19 06:30PM  Akorn Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Dec-21-18 02:00PM  Robbins Arroyo LLP: Shareholder Lawsuit Filed Against Officers and Directors of Akorn, Inc. (AKRX) Business Wire
12:57PM  Archer Capital Management Return, AUM, and Holdings Insider Monkey
07:58AM  The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial Benzinga
Dec-20-18 05:05PM  Akorn Names Douglas S. Boothe as President and CEO GlobeNewswire
Dec-14-18 04:25PM  Akorn, Inc. -- Moody's downgrades Akorn's ratings to Caa1; outlook revised to negative Moody's
Dec-10-18 03:18PM  Robbins Arroyo LLP: Shareholder Lawsuit Filed Against Officers and Directors of Akorn, Inc. (AKRX) Business Wire
01:24PM  After court case loss, drug maker Akorn's CEO will step down American City Business Journals
Dec-09-18 04:38AM  Is Akorn, Inc. (AKRX) A Good Stock To Buy? Insider Monkey
Dec-07-18 11:25PM  Akorn CEO to retire after drugmaker fails to salvage Fresenius merger deal Reuters -23.79%
08:27PM  Akorn CEO Steps Down After Loss of $4.3 Billion Fresenius Deal Bloomberg
05:04PM  Supreme Court of the State of Delaware Rules Against Akorn, New CEO Search Underway GlobeNewswire
01:08PM  Fresenius Wins Ruling on Canceled Buyout; Akorn Shares Fall Bloomberg
01:05AM  [$$] Akorn tumbles after US court upholds ruling on Fresenius deal cancellation Financial Times
Akorn, Inc., a specialty generic pharmaceutical company, develops, manufactures, and markets generic and branded prescription pharmaceuticals, over-the-counter (OTC) consumer health products, and animal health pharmaceuticals in the United States and internationally. The company operates in two segments, Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment offers generic and branded prescription pharmaceuticals in various dosage forms, including sterile ophthalmics, injectables, and inhalants; and non-sterile oral liquids, topicals, nasal sprays, and otics. Its primary products include Akten, a topical ocular anesthetic gel; AzaSite, an antibiotic used to treat bacterial conjunctivitis; Cosopt, Cosopt PF, Betimol, and Zioptan, which are used in the treatment of glaucoma; and Xopenex inhalation solution used in the treatment or prevention of bronchospasm. The Consumer Health segment manufactures and markets OTC products for the treatment of dry eye under the TheraTears brand. It also markets other OTC consumer health products comprising Mag-Ox, a magnesium supplement; and the Diabetic Tussin line of cough and cold products. In addition, this segment offers a portfolio of animal health products, such as Anased and VetaKet veterinary sedatives; Tolazine and Yobine sedative reversing agents; and Butorphic, a pain reliever. Akorn, Inc. was founded in 1971 and is headquartered in Lake Forest, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BONACCORSI JOSEPHEVP Gen Counsel & SecretaryDec 14Buy4.4825,000112,000541,283Dec 18 05:00 PM